Fears about German growth due to global conditions have been much overstated. German consumers are in a strong position.
The $155 billion combination of Pfizer and Allergan will face some hurdles. Price doesn’t seem to be one of them
Simon Potter is charged with implementing the mechanisms that will raise interest rates when Federal Reserve policy makers make that call.
American homeowners are digging out of the housing crisis. But housing wealth is playing a much smaller role in the overall economy than it did before the downturn.
Renewable-energy ‘yieldcos’ got everyone excited, then fizzled. Will they reinvent themselves?
It has been a tough year for many investors as the stock market has sputtered and shuddered like it hasn’t in a long time. And get ready for 2016, when the U.S. presidential election campaign has the potential to roil markets.
ETFs focused on aerospace-and-defense stocks took a dip this summer, but some analysts say they remain attractive.
A study finds that when investors run for cover, look out. (They are now.)
Monthly Monitor: U.S.-stock funds rose 6.2% in October, to trim the year-to-date decline for the funds to 0.1%.
Spotlight: The fund giant’s first municipal-bond index fund has had a quiet debut.